Relationship Between Diurnal Blood Pressure Variation and Diurnal Blood Glucose Levels in Type 2 Diabetic Patients

American Journal of Hypertension

Volumn 20, Issue 5, 2007, Pages 541-545

  Pistrosch, Frank ^a   Reissmann, Eva ^a   Wildbrett, Jan ^a   Koehler, Carsta ^b   Hanefeld, Markolf ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Ambulatory blood pressure monitoring; diurnal blood glucose; nondipping; type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 34247618741     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.10.010     Document Type: Article

References (30)

1. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317 (1998) 703-713
2. Roman M.J., Pickering T.G., Schwartz J.E., Cavallini M.C., Pini R., and Devereux R.B. Is the absence of nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage?. J Hypertens 15 (1997) 969-978
3. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 35 (2000) 844-851
4. Nakano S., Fukuda M., Hotta F., Ito T., Ishii T., Kitazawa M., Nishizawa M., Kigoshi T., and Uchida K. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 47 (1998) 1501-1506
5. Ohkubo T., Imai Y., Tsuij I., Nagai K., Watanabe N., and Minami N. Relation between nocturnal decline in blood pressure and mortality. The Ohasama study. Am J Hypertens 10 (1997) 1201-1207
6. Fogari R., Zopi A., Makamani G.D., Lazzari P., Albonico B., and Corradi L. Urinary albumin excretion and nocturnal blood pressure in hypertensive patients with type II diabetes mellitus. Am J Hypertens 7 (1994) 808-813
7. Equiluz-Bruck S., Schnack C., Kopp H.P., and Schernthaner G. Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertens 9 (1996) 1139-1143
8. Nakano S., Uchida K., Kigoshi T., Azukizawa S., Iwasaki R., Kaneko M., and Morimoto S. Circadian rhythm of blood pressure in normotensive NIDDM subjects: its relationship to microvascular complications. Diabetes Care 14 (1991) 707-711
9. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
10. Bonora E., and Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44 (2001) 2107-2114
11. Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., Ziegelasch H.J., and Lindner J. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39 (1996) 1577-1583
12. Ceriello A., Hanefeld M., Leiter L., Monnier L., Moses A., Owens D., Tajima N., and Tuomilehto J. Postprandial glucose regulation and diabetic complications. Arch Intern Med 164 (2004) 2090-2095
13. Zavaroni I., Coruzzi P., Bonini L., Mossini G.L., Musiari L., Gasparini P., Fantuzzi M., and Reaven G.M. Association between salt sensitivity and insulin concentrations in patients with hypertension. Am J Hypertension 8 (1995) 855-858
14. Chen J.W., Jen S.L., Lee W.L., Hsu N.W., Lin S.J., Ting C.T., Chang M.S., and Wang P.H. Differential glucose tolerance in dipper and nondipper essential hypertension. Diabetes Care 21 (1998) 1743-1748
15. European Society of Hypertension. 2003 guidelines for the management of arterial hypertension. J Hypertens 21 (2003) 1011-1053
16. Ziegler D., Laux G., Dannehl K., Spuler M., Muhlen H., and Mayer P. Assessment of cardiovascular autonomic function: age related normal ranges and reproducibility of spectral analysis, vector analysis and blood pressure responses. Diabet Med 9 (1992) 166-175
17. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26 (2003) 881-885
18. American Diabetes Association. : Diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl 1 (2004) S5-S10
19. Berne C., Fagius J., and Niklasson F. Sympathetic response to oral carbohydrate administration: evidence from microelectrode nerve recordings. J Clin Invest 84 (1989) 1403-1409
20. Laitinen T., Vauhkonen I.K.J., Hartikainen J.E.K., Länsimies E.A., Unsitupa M.I.J., and Laakso M. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients. Diabetes 48 (1999) 1295-1299
21. Masuo K., Mikami H., Ogihara T., and Tuck M.L. Differences in insulin and sympathetic response to glucose ingestion due to family history of hypertension. Am J Hypertens 9 (1996) 739-745
22. Moran A., Palmas W., Field L., Bhattarai J., Schwartz J.E., Weinstock R.S., and Shea S. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care 27 (2004) 972-977
23. Reaven G.M., Lithell H., and Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334 (1996) 374-381
24. Pistrosch F., Koehler C., Wildbrett J., and Hanefeld M. Relationship between diurnal glucose levels and HbA1c in type 2 diabetes. Horm Metab Res 38 (2006) 455-459
25. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidative therapy. Diabetes Care 26 (2003) 1589-1596
26. Esposito K., Giugliano D., Nappo F., and Marfella R. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110 (2004) 214-219
27. Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., and Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long term studies. Eur Heart J 25 (2004) 10-16
28. Cuspidi C., Meani S., Fusi V., Valerio C., Catini E., Sala C., Sampieri L., Magrini F., and Zanchetti A. Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J Hypertens 24 (2006) 647-653
29. Fogari R., Zoppi A., Malamani G.D., Lazzari P., Destro M., and Corradi L. Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am J Hypertens 6 (1993) 1-7
30. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Medicine 130 (1999) 461-470